Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Q&As

Monica Schwartzman
Q&A
Monica Schwartzman, MD, on Medication Preferences Among Patients With PsA
08/21/2023
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our...
08/21/2023
Rheumatology & Arthritis
Alexis Ogdie
Q&A
Alexis Ogdie, MD, on a Treat To Target Approach to Psoriatic Arthritis
06/29/2022
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving...
06/29/2022
Rheumatology & Arthritis
Joshua Baker, MD
Q&As
Elevations in Adipocytokines and Mortality in Rheumatoid Arthritis
04/21/2022
Joshua Baker, MD, from the Perelman School of Medicine at the University of Pennsylvania, answers our questions about his recent study into potential links between body mass, obesity, and the risk of death among patients with rheumatoid...
Joshua Baker, MD, from the Perelman School of Medicine at the University of Pennsylvania, answers our questions about his recent study into potential links between body mass, obesity, and the risk of death among patients with rheumatoid...
Joshua Baker, MD, from the...
04/21/2022
Rheumatology & Arthritis

Advertisement

Lianne Gensler
Q&A
Bimekizumab Therapy and Beyond for Ankylosing Spondylitis
02/01/2022
Lianne Gensler, MD, rheumatologist and director of the University of California, San Francisco, Spondyloarthritis Clinic, discussed the role of IL-17 in ankylosing spondylitis (AS) and the use of bimekizumab in treating this disease.
Lianne Gensler, MD, rheumatologist and director of the University of California, San Francisco, Spondyloarthritis Clinic, discussed the role of IL-17 in ankylosing spondylitis (AS) and the use of bimekizumab in treating this disease.
Lianne Gensler, MD,...
02/01/2022
Autoimmune
Celia Mead, Executive Director of BIRD
Q&As
Bath Institute for Rheumatic Diseases: Empowering Psoriatic Arthritis Researchers and Patients Alike
01/11/2022
Celia Mead, executive director of BIRD, spoke about the organization's initiatives for psoriatic arthritis and other diseases after receiving the UPLIFT Innovation Challenge grant.
Celia Mead, executive director of BIRD, spoke about the organization's initiatives for psoriatic arthritis and other diseases after receiving the UPLIFT Innovation Challenge grant.
Celia Mead, executive director...
01/11/2022
The Dermatologist
Q&As
Dr Joan Merrill: Insights on Anifrolumab
07/12/2021
Joan T. Merrill, MD, discusses her insights into anifrolumab and its benefits in treating moderate to severe systemic lupus erythematosus (SLE).
Joan T. Merrill, MD, discusses her insights into anifrolumab and its benefits in treating moderate to severe systemic lupus erythematosus (SLE).
Joan T. Merrill, MD, discusses...
07/12/2021
The Dermatologist

Advertisement

Jason Schairer, MD, on Dermatologic Manifestations in IBD
Q&As
Jason Schairer, MD, on Dermatologic Manifestations in IBD
06/06/2021
In this Q&A, Dr Schairer answers our questions about the presentation, diagnosis, and treatment of dermatological conditions among patients with inflammatory bowel disease.
In this Q&A, Dr Schairer answers our questions about the presentation, diagnosis, and treatment of dermatological conditions among patients with inflammatory bowel disease.
In this Q&A, Dr Schairer answers...
06/06/2021
Autoimmune
Dr Peter Lio on the Relationship Between AD and IMIDs
Q&As
Dr Peter Lio on the Relationship Between AD and IMIDs
04/16/2021
At the Interdisciplinary Autoimmune Summit 2021, Dr Lio spoke about emerging therapies for moderate to severe AD. In an interview with ALN, he answered several questions regarding advanced management of the disease.
At the Interdisciplinary Autoimmune Summit 2021, Dr Lio spoke about emerging therapies for moderate to severe AD. In an interview with ALN, he answered several questions regarding advanced management of the disease.
At the Interdisciplinary...
04/16/2021
The Dermatologist
Computer
Q&As
Q&A: Impact of COVID-19 on Patients With Psoriatic Arthritis
03/04/2021
Joseph F. Merola, MD, MMSc discussed the impact of the COVID-19 pandemic among patients with psoriatic arthritis.
Joseph F. Merola, MD, MMSc discussed the impact of the COVID-19 pandemic among patients with psoriatic arthritis.
Joseph F. Merola, MD, MMSc...
03/04/2021
Autoimmune

Advertisement

Thomas Werfel, MD, on the Safety of Tralokinumab for the Treatment of Atopic Dermatitis
Q&As
Thomas Werfel, MD, on the Safety of Tralokinumab for the Treatment of Atopic Dermatitis
02/11/2021
In this Q&A, Thomas Werfel, MD, discussed findings from pooled analyses that investigated the safety of tralokinumab among patients with atopic dermatitis.
In this Q&A, Thomas Werfel, MD, discussed findings from pooled analyses that investigated the safety of tralokinumab among patients with atopic dermatitis.
In this Q&A, Thomas Werfel, MD,...
02/11/2021
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles
Dermatology
Dr John Harris Discusses Vitiligo and the Most Common Comorbidities of the Disease
06/21/2021
Vitiligo, an autoimmune disease of the skin, can be debilitating for patients. While more study is needed to better understand relationships, John Harris, MD, PhD, details the most common comorbidities of vitiligo. Dr Harris is the chair of...
Vitiligo, an autoimmune disease of the skin, can be debilitating for patients. While more study is needed to better understand relationships, John Harris, MD, PhD, details the most common comorbidities of vitiligo. Dr Harris is the chair of...
Vitiligo, an autoimmune disease...
06/21/2021
Autoimmune
Conference Insights
Focusing on quality care and quality improvement in the acute hospitalized IBD patient
08/09/2018
08/09/2018
Autoimmune
Case Report
Renal Infarction in Ehlers-Danlos Syndrome
07/24/2019
Authors: Kohli Maanit, MD, and Balaji Yegneswaran, MD Saint Peter’s University Hospital, New Brunswick, New Jersey Citation: Maanit K, Yegneswaran B. Renal infarction in Ehlers-Danlos syndrome. Consultant....
Authors: Kohli Maanit, MD, and Balaji Yegneswaran, MD Saint Peter’s University Hospital, New Brunswick, New Jersey Citation: Maanit K, Yegneswaran B. Renal infarction in Ehlers-Danlos syndrome. Consultant....
...
07/24/2019
Rheumatology & Arthritis
News
Expert Recommendations for Managing Autoimmune Bullous Diseases in COVID-19 Era
05/18/2020
Experts from the United States, France, and Germany published guidance on managing patients with autoimmune bullous diseases during the COVID-19 pandemic.
Experts from the United States, France, and Germany published guidance on managing patients with autoimmune bullous diseases during the COVID-19 pandemic.
Experts from the United States,...
05/18/2020
Autoimmune
News
More Trial Participation Needed By Black Patients With SLE
07/13/2021
Researchers stress the importance of clinical trial participation among Black patients with systemic lupus erythematous, and how racial bias in health care creates distrust among these patients.
Researchers stress the importance of clinical trial participation among Black patients with systemic lupus erythematous, and how racial bias in health care creates distrust among these patients.
Researchers stress the...
07/13/2021
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay In the Know

Autoimmune Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use